

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fatty acid transmembrane transport (GO:1902001) | 9.46236961 |
| 2 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 8.88130827 |
| 3 | tricarboxylic acid cycle (GO:0006099) | 8.63461948 |
| 4 | biotin metabolic process (GO:0006768) | 8.45306765 |
| 5 | NADH metabolic process (GO:0006734) | 8.28506140 |
| 6 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 8.15969712 |
| 7 | regulation of fatty acid oxidation (GO:0046320) | 7.98595084 |
| 8 | fatty acid beta-oxidation (GO:0006635) | 7.85651576 |
| 9 | carnitine transmembrane transport (GO:1902603) | 7.83259895 |
| 10 | regulation of cofactor metabolic process (GO:0051193) | 7.72993142 |
| 11 | regulation of coenzyme metabolic process (GO:0051196) | 7.72993142 |
| 12 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 7.23826044 |
| 13 | positive regulation of fatty acid oxidation (GO:0046321) | 7.21960034 |
| 14 | carnitine transport (GO:0015879) | 7.17632046 |
| 15 | amino-acid betaine transport (GO:0015838) | 7.17632046 |
| 16 | brown fat cell differentiation (GO:0050873) | 6.90875934 |
| 17 | fatty acid oxidation (GO:0019395) | 6.54074397 |
| 18 | fatty acid catabolic process (GO:0009062) | 6.53526944 |
| 19 | lipid oxidation (GO:0034440) | 6.42816232 |
| 20 | regulation of sulfur metabolic process (GO:0042762) | 6.22062627 |
| 21 | triglyceride catabolic process (GO:0019433) | 6.15993191 |
| 22 | white fat cell differentiation (GO:0050872) | 6.01965639 |
| 23 | acetyl-CoA metabolic process (GO:0006084) | 5.86415602 |
| 24 | acyl-CoA biosynthetic process (GO:0071616) | 5.70967412 |
| 25 | thioester biosynthetic process (GO:0035384) | 5.70967412 |
| 26 | regulation of fatty acid beta-oxidation (GO:0031998) | 5.68778649 |
| 27 | intracellular lipid transport (GO:0032365) | 5.67498538 |
| 28 | coenzyme A biosynthetic process (GO:0015937) | 5.63903202 |
| 29 | lipid particle organization (GO:0034389) | 5.59803065 |
| 30 | acylglycerol catabolic process (GO:0046464) | 5.56717526 |
| 31 | neutral lipid catabolic process (GO:0046461) | 5.56717526 |
| 32 | succinate metabolic process (GO:0006105) | 5.52772381 |
| 33 | triglyceride biosynthetic process (GO:0019432) | 5.52478633 |
| 34 | branched-chain amino acid catabolic process (GO:0009083) | 5.34171703 |
| 35 | lipid storage (GO:0019915) | 5.33873950 |
| 36 | neutral lipid biosynthetic process (GO:0046460) | 5.27857112 |
| 37 | acylglycerol biosynthetic process (GO:0046463) | 5.27857112 |
| 38 | low-density lipoprotein particle clearance (GO:0034383) | 5.26587017 |
| 39 | quaternary ammonium group transport (GO:0015697) | 5.23201478 |
| 40 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 5.01881876 |
| 41 | positive regulation of lipid storage (GO:0010884) | 5.00520573 |
| 42 | proline transport (GO:0015824) | 4.97500906 |
| 43 | valine metabolic process (GO:0006573) | 4.95132074 |
| 44 | monocarboxylic acid catabolic process (GO:0072329) | 4.92077193 |
| 45 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 4.86124734 |
| 46 | glycine transport (GO:0015816) | 4.79245694 |
| 47 | branched-chain amino acid metabolic process (GO:0009081) | 4.78102456 |
| 48 | tricarboxylic acid metabolic process (GO:0072350) | 4.71685264 |
| 49 | lysine metabolic process (GO:0006553) | 4.71151151 |
| 50 | lysine catabolic process (GO:0006554) | 4.71151151 |
| 51 | regulation of triglyceride catabolic process (GO:0010896) | 4.70704287 |
| 52 | short-chain fatty acid metabolic process (GO:0046459) | 4.68760778 |
| 53 | regulation of cholesterol storage (GO:0010885) | 4.66406320 |
| 54 | alanine transport (GO:0032328) | 4.65009040 |
| 55 | fatty-acyl-CoA metabolic process (GO:0035337) | 4.60784314 |
| 56 | carnitine metabolic process (GO:0009437) | 4.49478044 |
| 57 | cardiolipin metabolic process (GO:0032048) | 4.45245961 |
| 58 | coenzyme A metabolic process (GO:0015936) | 4.42092554 |
| 59 | positive regulation of lipid catabolic process (GO:0050996) | 4.37071078 |
| 60 | negative regulation of fatty acid metabolic process (GO:0045922) | 4.34475308 |
| 61 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.22891527 |
| 62 | regulation of fatty acid metabolic process (GO:0019217) | 4.18951221 |
| 63 | glycerolipid catabolic process (GO:0046503) | 4.09977152 |
| 64 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.09466546 |
| 65 | long-chain fatty acid transport (GO:0015909) | 4.07776621 |
| 66 | acyl-CoA metabolic process (GO:0006637) | 4.03527123 |
| 67 | thioester metabolic process (GO:0035383) | 4.03527123 |
| 68 | positive regulation of glycolytic process (GO:0045821) | 3.99813962 |
| 69 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.87826247 |
| 70 | regulation of lipid storage (GO:0010883) | 3.85833052 |
| 71 | triglyceride metabolic process (GO:0006641) | 3.85225410 |
| 72 | cellular lipid catabolic process (GO:0044242) | 3.84142372 |
| 73 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.81965060 |
| 74 | alpha-linolenic acid metabolic process (GO:0036109) | 3.76246907 |
| 75 | respiratory electron transport chain (GO:0022904) | 3.75762709 |
| 76 | pentose-phosphate shunt (GO:0006098) | 3.73875270 |
| 77 | negative regulation of lipid storage (GO:0010888) | 3.73256812 |
| 78 | electron transport chain (GO:0022900) | 3.66732683 |
| 79 | acylglycerol metabolic process (GO:0006639) | 3.64716807 |
| 80 | neutral lipid metabolic process (GO:0006638) | 3.60109246 |
| 81 | NADPH regeneration (GO:0006740) | 3.55165793 |
| 82 | temperature homeostasis (GO:0001659) | 3.52474164 |
| 83 | negative regulation of lipid catabolic process (GO:0050995) | 3.51771352 |
| 84 | response to phenylpropanoid (GO:0080184) | 3.51444599 |
| 85 | negative regulation of lipase activity (GO:0060192) | 3.50540172 |
| 86 | glycerol metabolic process (GO:0006071) | 3.49760275 |
| 87 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.47632963 |
| 88 | regulation of lipid catabolic process (GO:0050994) | 3.46139132 |
| 89 | fatty acid transport (GO:0015908) | 3.44396534 |
| 90 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.42524613 |
| 91 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 3.39671503 |
| 92 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 3.39671503 |
| 93 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 3.39671503 |
| 94 | cellular response to lithium ion (GO:0071285) | 3.38778513 |
| 95 | amino-acid betaine metabolic process (GO:0006577) | 3.32469857 |
| 96 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.32364680 |
| 97 | lipid modification (GO:0030258) | 3.27899624 |
| 98 | phosphatidic acid biosynthetic process (GO:0006654) | 3.27719243 |
| 99 | regulation of sequestering of triglyceride (GO:0010889) | 11.6158693 |
| 100 | carnitine shuttle (GO:0006853) | 10.2450259 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 8.00685453 |
| 2 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.97544090 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.57195175 |
| 4 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.13102026 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.90757316 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.74920410 |
| 7 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.60565347 |
| 8 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.47176077 |
| 9 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.44062204 |
| 10 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.39001141 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.28019448 |
| 12 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 2.13405168 |
| 13 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 2.10158526 |
| 14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.05407345 |
| 15 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 2.02352556 |
| 16 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.00633689 |
| 17 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 15.9724135 |
| 18 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.86191169 |
| 19 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.74275004 |
| 20 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.68843959 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.64122401 |
| 22 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.62869065 |
| 23 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.53675004 |
| 24 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.48370985 |
| 25 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.42232326 |
| 26 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33356096 |
| 27 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.32766034 |
| 28 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.29046878 |
| 29 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.25909691 |
| 30 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.25549898 |
| 31 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23803238 |
| 32 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.23358625 |
| 33 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.22030193 |
| 34 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.20055540 |
| 35 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.10385974 |
| 36 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.07330217 |
| 37 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.06247808 |
| 38 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.04726383 |
| 39 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.04726383 |
| 40 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.04059362 |
| 41 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.02342158 |
| 42 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.00156706 |
| 43 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.99536717 |
| 44 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.98164515 |
| 45 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97408149 |
| 46 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.96140457 |
| 47 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.92838223 |
| 48 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.85675338 |
| 49 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.85378486 |
| 50 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.83223505 |
| 51 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.83223505 |
| 52 | ATF3_27146783_Chip-Seq_COLON_Human | 0.81836967 |
| 53 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81620838 |
| 54 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.80774536 |
| 55 | * ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.80219118 |
| 56 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.79403398 |
| 57 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.79173806 |
| 58 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.78396663 |
| 59 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.76962144 |
| 60 | GATA1_22025678_ChIP-Seq_K562_Human | 0.76895227 |
| 61 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.76839147 |
| 62 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.75767421 |
| 63 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.75478972 |
| 64 | * RXR_22108803_ChIP-Seq_LS180_Human | 0.75214212 |
| 65 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.75193683 |
| 66 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.74371904 |
| 67 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.73701551 |
| 68 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.73478608 |
| 69 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.73236075 |
| 70 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.72000125 |
| 71 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.72000125 |
| 72 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.70605461 |
| 73 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.69688686 |
| 74 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.69203997 |
| 75 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.66226116 |
| 76 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.64257952 |
| 77 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.63763475 |
| 78 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.63186526 |
| 79 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.62362458 |
| 80 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.61167513 |
| 81 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.59989124 |
| 82 | GATA1_19941826_ChIP-Seq_K562_Human | 0.58756674 |
| 83 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.58361213 |
| 84 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.58302882 |
| 85 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.57604513 |
| 86 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.57104617 |
| 87 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56258699 |
| 88 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.55552392 |
| 89 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.54462171 |
| 90 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.54462048 |
| 91 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.54327083 |
| 92 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.51854293 |
| 93 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.51484842 |
| 94 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.51012227 |
| 95 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.50996734 |
| 96 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.50822895 |
| 97 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.50136870 |
| 98 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.49684404 |
| 99 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.48318070 |
| 100 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.48137786 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 8.56827740 |
| 2 | MP0005666_abnormal_adipose_tissue | 6.12007072 |
| 3 | MP0004130_abnormal_muscle_cell | 5.14471140 |
| 4 | MP0002971_abnormal_brown_adipose | 5.10383021 |
| 5 | MP0004185_abnormal_adipocyte_glucose | 5.00246689 |
| 6 | MP0002837_dystrophic_cardiac_calcinosis | 4.58697692 |
| 7 | MP0005375_adipose_tissue_phenotype | 4.13620816 |
| 8 | MP0005535_abnormal_body_temperature | 3.28421571 |
| 9 | MP0003646_muscle_fatigue | 3.11629476 |
| 10 | MP0000003_abnormal_adipose_tissue | 2.98156615 |
| 11 | MP0006036_abnormal_mitochondrial_physio | 2.90042723 |
| 12 | MP0000013_abnormal_adipose_tissue | 2.88319275 |
| 13 | MP0002970_abnormal_white_adipose | 2.74319305 |
| 14 | MP0009115_abnormal_fat_cell | 2.63497083 |
| 15 | MP0010329_abnormal_lipoprotein_level | 2.30423103 |
| 16 | MP0002118_abnormal_lipid_homeostasis | 2.30101417 |
| 17 | MP0005334_abnormal_fat_pad | 2.29970214 |
| 18 | MP0005330_cardiomyopathy | 1.98072661 |
| 19 | MP0005448_abnormal_energy_balance | 1.81468719 |
| 20 | MP0002078_abnormal_glucose_homeostasis | 1.71794281 |
| 21 | MP0005332_abnormal_amino_acid | 1.62748471 |
| 22 | MP0005452_abnormal_adipose_tissue | 1.60010295 |
| 23 | MP0008438_abnormal_cutaneous_collagen | 1.58463569 |
| 24 | MP0008961_abnormal_basal_metabolism | 1.51829360 |
| 25 | MP0000609_abnormal_liver_physiology | 1.50113612 |
| 26 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.49877891 |
| 27 | MP0003221_abnormal_cardiomyocyte_apopto | 1.39717046 |
| 28 | MP0003959_abnormal_lean_body | 1.36582416 |
| 29 | MP0002332_abnormal_exercise_endurance | 1.35187129 |
| 30 | MP0008775_abnormal_heart_ventricle | 1.29876296 |
| 31 | MP0001661_extended_life_span | 1.29256559 |
| 32 | MP0005365_abnormal_bile_salt | 1.20519039 |
| 33 | MP0003724_increased_susceptibility_to | 1.17674521 |
| 34 | MP0004087_abnormal_muscle_fiber | 1.17541684 |
| 35 | MP0001881_abnormal_mammary_gland | 1.14893765 |
| 36 | MP0010234_abnormal_vibrissa_follicle | 1.12143814 |
| 37 | MP0003690_abnormal_glial_cell | 1.03900816 |
| 38 | MP0003191_abnormal_cellular_cholesterol | 1.03206739 |
| 39 | MP0006035_abnormal_mitochondrial_morpho | 1.00819127 |
| 40 | MP0006138_congestive_heart_failure | 1.00255952 |
| 41 | MP0003879_abnormal_hair_cell | 0.99454412 |
| 42 | MP0005385_cardiovascular_system_phenoty | 0.97201173 |
| 43 | MP0001544_abnormal_cardiovascular_syste | 0.97201173 |
| 44 | MP0004272_abnormal_basement_membrane | 0.95929484 |
| 45 | MP0003705_abnormal_hypodermis_morpholog | 0.95160990 |
| 46 | MP0005275_abnormal_skin_tensile | 0.92998661 |
| 47 | MP0008872_abnormal_physiological_respon | 0.92606865 |
| 48 | MP0002877_abnormal_melanocyte_morpholog | 0.89598471 |
| 49 | MP0003566_abnormal_cell_adhesion | 0.88919195 |
| 50 | MP0003953_abnormal_hormone_level | 0.87586545 |
| 51 | MP0010630_abnormal_cardiac_muscle | 0.84800978 |
| 52 | MP0003948_abnormal_gas_homeostasis | 0.84678275 |
| 53 | MP0001853_heart_inflammation | 0.83297545 |
| 54 | MP0001485_abnormal_pinna_reflex | 0.81429918 |
| 55 | MP0003878_abnormal_ear_physiology | 0.81147322 |
| 56 | MP0005377_hearing/vestibular/ear_phenot | 0.81147322 |
| 57 | MP0000759_abnormal_skeletal_muscle | 0.80946421 |
| 58 | MP0000343_altered_response_to | 0.76865067 |
| 59 | MP0005319_abnormal_enzyme/_coenzyme | 0.75945398 |
| 60 | MP0002909_abnormal_adrenal_gland | 0.75092479 |
| 61 | MP0005076_abnormal_cell_differentiation | 0.72597599 |
| 62 | MP0004147_increased_porphyrin_level | 0.71170936 |
| 63 | MP0006054_spinal_hemorrhage | 0.69980917 |
| 64 | MP0001879_abnormal_lymphatic_vessel | 0.69809808 |
| 65 | MP0004215_abnormal_myocardial_fiber | 0.68546268 |
| 66 | MP0003186_abnormal_redox_activity | 0.68293419 |
| 67 | MP0004233_abnormal_muscle_weight | 0.67343057 |
| 68 | MP0009643_abnormal_urine_homeostasis | 0.66941928 |
| 69 | MP0004134_abnormal_chest_morphology | 0.65466012 |
| 70 | MP0002269_muscular_atrophy | 0.65086978 |
| 71 | MP0001727_abnormal_embryo_implantation | 0.64853207 |
| 72 | MP0002876_abnormal_thyroid_physiology | 0.63421682 |
| 73 | MP0005620_abnormal_muscle_contractility | 0.63022882 |
| 74 | MP0002972_abnormal_cardiac_muscle | 0.62498728 |
| 75 | MP0003045_fibrosis | 0.59748607 |
| 76 | MP0005645_abnormal_hypothalamus_physiol | 0.58781744 |
| 77 | MP0003950_abnormal_plasma_membrane | 0.58603446 |
| 78 | MP0002796_impaired_skin_barrier | 0.57342828 |
| 79 | MP0002139_abnormal_hepatobiliary_system | 0.55784233 |
| 80 | MP0004043_abnormal_pH_regulation | 0.54664694 |
| 81 | MP0005266_abnormal_metabolism | 0.53390826 |
| 82 | MP0004484_altered_response_of | 0.51954174 |
| 83 | MP0010352_gastrointestinal_tract_polyps | 0.50133381 |
| 84 | MP0003329_amyloid_beta_deposits | 0.49597757 |
| 85 | MP0002060_abnormal_skin_morphology | 0.44987669 |
| 86 | MP0005085_abnormal_gallbladder_physiolo | 0.43286787 |
| 87 | MP0002106_abnormal_muscle_physiology | 0.42188780 |
| 88 | MP0004924_abnormal_behavior | 0.41855862 |
| 89 | MP0005386_behavior/neurological_phenoty | 0.41855862 |
| 90 | MP0000598_abnormal_liver_morphology | 0.40942665 |
| 91 | MP0001756_abnormal_urination | 0.40436185 |
| 92 | MP0000604_amyloidosis | 0.38879303 |
| 93 | MP0002166_altered_tumor_susceptibility | 0.38006313 |
| 94 | MP0009642_abnormal_blood_homeostasis | 0.37582606 |
| 95 | MP0000750_abnormal_muscle_regeneration | 0.37363733 |
| 96 | MP0003195_calcinosis | 0.35789921 |
| 97 | MP0000230_abnormal_systemic_arterial | 0.34235529 |
| 98 | MP0003300_gastrointestinal_ulcer | 0.33901893 |
| 99 | MP0003633_abnormal_nervous_system | 0.33574236 |
| 100 | MP0000747_muscle_weakness | 0.33447432 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperglycinuria (HP:0003108) | 7.56402760 |
| 2 | Myoglobinuria (HP:0002913) | 6.96748715 |
| 3 | Hypoglycemic coma (HP:0001325) | 6.69386902 |
| 4 | Abnormality of fatty-acid metabolism (HP:0004359) | 6.43231370 |
| 5 | Rhabdomyolysis (HP:0003201) | 6.31773096 |
| 6 | Dicarboxylic aciduria (HP:0003215) | 6.20005082 |
| 7 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 6.20005082 |
| 8 | Abnormality of glycine metabolism (HP:0010895) | 5.94098180 |
| 9 | Abnormality of serine family amino acid metabolism (HP:0010894) | 5.94098180 |
| 10 | Hydroxyprolinuria (HP:0003080) | 5.28411263 |
| 11 | Abnormality of proline metabolism (HP:0010907) | 5.28411263 |
| 12 | Hepatic necrosis (HP:0002605) | 5.09997928 |
| 13 | Increased muscle lipid content (HP:0009058) | 5.02087599 |
| 14 | Renal cortical cysts (HP:0000803) | 4.56585804 |
| 15 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 4.56241195 |
| 16 | Generalized aminoaciduria (HP:0002909) | 4.54438893 |
| 17 | Oligomenorrhea (HP:0000876) | 4.52681903 |
| 18 | Difficulty running (HP:0009046) | 4.33149199 |
| 19 | Hyperammonemia (HP:0001987) | 4.27851432 |
| 20 | Ketoacidosis (HP:0001993) | 4.21179194 |
| 21 | Acanthosis nigricans (HP:0000956) | 3.99912516 |
| 22 | Limb hypertonia (HP:0002509) | 3.98212235 |
| 23 | Nausea (HP:0002018) | 3.88450387 |
| 24 | Ketosis (HP:0001946) | 3.83960494 |
| 25 | Hyperglycinemia (HP:0002154) | 3.83211198 |
| 26 | Hypertriglyceridemia (HP:0002155) | 3.75163308 |
| 27 | Hyperalaninemia (HP:0003348) | 3.65692147 |
| 28 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.65692147 |
| 29 | Abnormality of alanine metabolism (HP:0010916) | 3.65692147 |
| 30 | Methylmalonic aciduria (HP:0012120) | 3.63736712 |
| 31 | Increased serum pyruvate (HP:0003542) | 3.57483926 |
| 32 | Abnormality of glycolysis (HP:0004366) | 3.57483926 |
| 33 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.41881278 |
| 34 | Hepatocellular necrosis (HP:0001404) | 3.28216864 |
| 35 | Proximal tubulopathy (HP:0000114) | 3.22678889 |
| 36 | Acute encephalopathy (HP:0006846) | 3.15570416 |
| 37 | Bone cyst (HP:0012062) | 3.14508923 |
| 38 | Cerebral edema (HP:0002181) | 3.13947547 |
| 39 | Conjunctival hamartoma (HP:0100780) | 3.12202144 |
| 40 | Lactic acidosis (HP:0003128) | 3.07630527 |
| 41 | Lethargy (HP:0001254) | 3.06152207 |
| 42 | Pheochromocytoma (HP:0002666) | 2.95051597 |
| 43 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.93170018 |
| 44 | Exercise-induced myalgia (HP:0003738) | 2.90267285 |
| 45 | Long foot (HP:0001833) | 2.90148032 |
| 46 | Muscle stiffness (HP:0003552) | 2.82357258 |
| 47 | Methylmalonic acidemia (HP:0002912) | 2.80533345 |
| 48 | Increased intramyocellular lipid droplets (HP:0012240) | 2.75459746 |
| 49 | Neonatal death (HP:0003811) | 2.73206814 |
| 50 | Esophageal neoplasm (HP:0100751) | 2.68320097 |
| 51 | Neoplasm of head and neck (HP:0012288) | 2.68320097 |
| 52 | Abnormality of serum amino acid levels (HP:0003112) | 2.66779667 |
| 53 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.63223554 |
| 54 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.60856779 |
| 55 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.60856779 |
| 56 | Athetosis (HP:0002305) | 2.59760989 |
| 57 | Acute necrotizing encephalopathy (HP:0006965) | 2.59544141 |
| 58 | Neuroendocrine neoplasm (HP:0100634) | 2.53818616 |
| 59 | Respiratory failure (HP:0002878) | 2.50571330 |
| 60 | Tachypnea (HP:0002789) | 2.43424115 |
| 61 | Facial diplegia (HP:0001349) | 2.42856062 |
| 62 | Increased CSF lactate (HP:0002490) | 2.42183917 |
| 63 | Large hands (HP:0001176) | 2.40472820 |
| 64 | Vomiting (HP:0002013) | 2.40346581 |
| 65 | Hamartoma of the eye (HP:0010568) | 2.37702768 |
| 66 | Lipid accumulation in hepatocytes (HP:0006561) | 2.37639614 |
| 67 | Metabolic acidosis (HP:0001942) | 2.31331761 |
| 68 | Progressive macrocephaly (HP:0004481) | 2.30289085 |
| 69 | Insulin resistance (HP:0000855) | 2.26412251 |
| 70 | Growth hormone excess (HP:0000845) | 2.24149306 |
| 71 | Hypoalphalipoproteinemia (HP:0003233) | 2.18384887 |
| 72 | Abnormality of the renal cortex (HP:0011035) | 2.16058519 |
| 73 | Cerebral hemorrhage (HP:0001342) | 2.12940019 |
| 74 | Palpitations (HP:0001962) | 2.12921452 |
| 75 | Prenatal maternal abnormality (HP:0002686) | 2.12695121 |
| 76 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.10946228 |
| 77 | Pancreatitis (HP:0001733) | 2.10515726 |
| 78 | Mitochondrial inheritance (HP:0001427) | 2.06459013 |
| 79 | Tetraparesis (HP:0002273) | 1.98596494 |
| 80 | Multiple enchondromatosis (HP:0005701) | 1.98008191 |
| 81 | Dysmetric saccades (HP:0000641) | 1.90618374 |
| 82 | Neoplasm of the rectum (HP:0100743) | 1.89959166 |
| 83 | Neonatal hypoglycemia (HP:0001998) | 1.88840230 |
| 84 | Increased connective tissue (HP:0009025) | 1.88192078 |
| 85 | Exercise intolerance (HP:0003546) | 1.82867354 |
| 86 | Neoplasm of the adrenal gland (HP:0100631) | 1.81244440 |
| 87 | Clitoromegaly (HP:0000057) | 1.80765459 |
| 88 | Hypoglycemic seizures (HP:0002173) | 1.80427853 |
| 89 | Epidermoid cyst (HP:0200040) | 1.77989108 |
| 90 | Respiratory distress (HP:0002098) | 1.77542899 |
| 91 | Neoplasm of the small intestine (HP:0100833) | 1.74736836 |
| 92 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.74129745 |
| 93 | Hyperglycemia (HP:0003074) | 1.72973975 |
| 94 | Increased serum lactate (HP:0002151) | 1.70815524 |
| 95 | Toxemia of pregnancy (HP:0100603) | 1.68362268 |
| 96 | Abnormal cartilage morphology (HP:0002763) | 1.67732246 |
| 97 | Adenoma sebaceum (HP:0009720) | 1.66287024 |
| 98 | Angiofibromas (HP:0010615) | 1.66287024 |
| 99 | Acute hepatic failure (HP:0006554) | 1.64545625 |
| 100 | Gliosis (HP:0002171) | 1.63307913 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.30766477 |
| 2 | PDK3 | 5.90152552 |
| 3 | PDK4 | 5.90152552 |
| 4 | CAMK1D | 5.65359745 |
| 5 | TRIB3 | 5.55030218 |
| 6 | CAMK1G | 3.94386418 |
| 7 | PDK2 | 3.66460181 |
| 8 | SIK1 | 2.94148643 |
| 9 | PRKAA2 | 2.06996830 |
| 10 | PKN2 | 2.03395242 |
| 11 | LATS1 | 1.48909212 |
| 12 | CDK9 | 1.36943629 |
| 13 | RIPK1 | 1.31242549 |
| 14 | PDPK1 | 1.30349397 |
| 15 | CDK6 | 1.27442904 |
| 16 | PRKD3 | 1.27144962 |
| 17 | INSRR | 1.21545610 |
| 18 | PDK1 | 1.14921486 |
| 19 | PRKAA1 | 1.09176297 |
| 20 | MAP2K1 | 1.02160920 |
| 21 | PDGFRA | 0.99883028 |
| 22 | FRK | 0.87198446 |
| 23 | MST1R | 0.85237584 |
| 24 | LMTK2 | 0.84939243 |
| 25 | FGFR3 | 0.84718627 |
| 26 | NEK1 | 0.82676099 |
| 27 | TIE1 | 0.74612224 |
| 28 | STK3 | 0.74370453 |
| 29 | LATS2 | 0.72968086 |
| 30 | CDK4 | 0.72407631 |
| 31 | TGFBR2 | 0.72331850 |
| 32 | PRKCH | 0.71176531 |
| 33 | PRKACG | 0.70154578 |
| 34 | ILK | 0.66122016 |
| 35 | MTOR | 0.65702261 |
| 36 | FLT3 | 0.64658512 |
| 37 | FGFR2 | 0.60505616 |
| 38 | FGFR4 | 0.59416937 |
| 39 | JAK1 | 0.57115507 |
| 40 | FER | 0.55630027 |
| 41 | RET | 0.55141335 |
| 42 | KSR2 | 0.52772226 |
| 43 | MAP3K6 | 0.51721785 |
| 44 | NEK9 | 0.50983256 |
| 45 | EPHA2 | 0.50228283 |
| 46 | ERN1 | 0.49875741 |
| 47 | PINK1 | 0.49044623 |
| 48 | MAPK11 | 0.48674271 |
| 49 | JAK2 | 0.48615863 |
| 50 | PRKD1 | 0.47902883 |
| 51 | AKT2 | 0.46972974 |
| 52 | GSK3A | 0.46367847 |
| 53 | EIF2AK2 | 0.43723047 |
| 54 | PTK6 | 0.42826655 |
| 55 | ICK | 0.39916783 |
| 56 | STK38L | 0.39546669 |
| 57 | IRAK3 | 0.38673766 |
| 58 | MAP3K2 | 0.38641350 |
| 59 | MET | 0.34650454 |
| 60 | DYRK1B | 0.33451224 |
| 61 | SCYL2 | 0.33206717 |
| 62 | PRKD2 | 0.32953486 |
| 63 | IGF1R | 0.32905582 |
| 64 | INSR | 0.32815807 |
| 65 | TRPM7 | 0.32482271 |
| 66 | STK11 | 0.31806066 |
| 67 | SGK3 | 0.30388077 |
| 68 | BMX | 0.30299632 |
| 69 | BCR | 0.29738357 |
| 70 | FGFR1 | 0.28627413 |
| 71 | PDGFRB | 0.28566092 |
| 72 | TTK | 0.27856581 |
| 73 | EPHB2 | 0.27374296 |
| 74 | CAMK1 | 0.27256021 |
| 75 | RPS6KB1 | 0.25980860 |
| 76 | DDR2 | 0.25342202 |
| 77 | AKT1 | 0.24731723 |
| 78 | EPHB1 | 0.24439202 |
| 79 | NTRK3 | 0.24193070 |
| 80 | ABL2 | 0.23641951 |
| 81 | PHKG2 | 0.22328672 |
| 82 | PHKG1 | 0.22328672 |
| 83 | TTN | 0.21673950 |
| 84 | LRRK2 | 0.20327715 |
| 85 | EEF2K | 0.20234305 |
| 86 | PAK6 | 0.20114020 |
| 87 | PRKCE | 0.19924864 |
| 88 | EPHA3 | 0.19251054 |
| 89 | IRAK1 | 0.18798500 |
| 90 | RPS6KA3 | 0.18288272 |
| 91 | SGK494 | 0.18023157 |
| 92 | SGK223 | 0.18023157 |
| 93 | CSNK1G1 | 0.16764109 |
| 94 | DYRK2 | 0.16748541 |
| 95 | CDK5 | 0.16719391 |
| 96 | RPS6KA1 | 0.15923894 |
| 97 | SRC | 0.15528166 |
| 98 | MAPK8 | 0.10685406 |
| 99 | PIK3CA | 0.10682171 |
| 100 | PRKACA | 0.10152992 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 6.57513096 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 5.73519810 |
| 3 | Fatty acid metabolism_Homo sapiens_hsa01212 | 4.64765413 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 4.54466228 |
| 5 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 4.02954752 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 4.02467338 |
| 7 | PPAR signaling pathway_Homo sapiens_hsa03320 | 3.60526352 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.31571897 |
| 9 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.85248498 |
| 10 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.77630187 |
| 11 | Carbon metabolism_Homo sapiens_hsa01200 | 2.69334909 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.66875304 |
| 13 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.25311216 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.89545565 |
| 15 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.65112127 |
| 16 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.58639274 |
| 17 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.54198856 |
| 18 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.39469649 |
| 19 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.28363321 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.21371652 |
| 21 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.21012391 |
| 22 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.19441652 |
| 23 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.11512795 |
| 24 | Insulin resistance_Homo sapiens_hsa04931 | 1.06149424 |
| 25 | Parkinsons disease_Homo sapiens_hsa05012 | 1.05187832 |
| 26 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.05169100 |
| 27 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.02134664 |
| 28 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.01388466 |
| 29 | Lysine degradation_Homo sapiens_hsa00310 | 0.91544080 |
| 30 | Huntingtons disease_Homo sapiens_hsa05016 | 0.83921495 |
| 31 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.78416168 |
| 32 | Alzheimers disease_Homo sapiens_hsa05010 | 0.77903146 |
| 33 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.77750336 |
| 34 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.75410685 |
| 35 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.69472038 |
| 36 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64524274 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.59420144 |
| 38 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.58676648 |
| 39 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55707467 |
| 40 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.55681227 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.52134207 |
| 42 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.50034920 |
| 43 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.49296631 |
| 44 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.45534808 |
| 45 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.42980353 |
| 46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.38430510 |
| 47 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.32848994 |
| 48 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.32584323 |
| 49 | Metabolic pathways_Homo sapiens_hsa01100 | 0.32486488 |
| 50 | Renin secretion_Homo sapiens_hsa04924 | 0.30683183 |
| 51 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.28837690 |
| 52 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.27560552 |
| 53 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.23844808 |
| 54 | Galactose metabolism_Homo sapiens_hsa00052 | 0.22974585 |
| 55 | Thyroid cancer_Homo sapiens_hsa05216 | 0.22030973 |
| 56 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.20088252 |
| 57 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.19448047 |
| 58 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.19028375 |
| 59 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.18370750 |
| 60 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.17326397 |
| 61 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.15062802 |
| 62 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.13002844 |
| 63 | ABC transporters_Homo sapiens_hsa02010 | 0.09434536 |
| 64 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.09423726 |
| 65 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.06422313 |
| 66 | Salivary secretion_Homo sapiens_hsa04970 | 0.05754528 |
| 67 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.05108608 |
| 68 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.05014223 |
| 69 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.04852410 |
| 70 | Focal adhesion_Homo sapiens_hsa04510 | 0.03500556 |
| 71 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.03481846 |
| 72 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.00913748 |
| 73 | Choline metabolism in cancer_Homo sapiens_hsa05231 | -0.1034040 |
| 74 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.1021898 |
| 75 | Toxoplasmosis_Homo sapiens_hsa05145 | -0.1008101 |
| 76 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | -0.1000035 |
| 77 | Glutathione metabolism_Homo sapiens_hsa00480 | -0.0985273 |
| 78 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | -0.0942676 |
| 79 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | -0.0833069 |
| 80 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | -0.0804621 |
| 81 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | -0.0795684 |
| 82 | Viral myocarditis_Homo sapiens_hsa05416 | -0.0766508 |
| 83 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | -0.0764118 |
| 84 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.0751141 |
| 85 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | -0.0725745 |
| 86 | Tight junction_Homo sapiens_hsa04530 | -0.0723042 |
| 87 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | -0.0709351 |
| 88 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | -0.0698216 |
| 89 | Bile secretion_Homo sapiens_hsa04976 | -0.0667425 |
| 90 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | -0.0622617 |
| 91 | Proteoglycans in cancer_Homo sapiens_hsa05205 | -0.0604257 |
| 92 | Amoebiasis_Homo sapiens_hsa05146 | -0.0579186 |
| 93 | cAMP signaling pathway_Homo sapiens_hsa04024 | -0.0527682 |
| 94 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0509049 |
| 95 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.0497111 |
| 96 | Estrogen signaling pathway_Homo sapiens_hsa04915 | -0.0405295 |
| 97 | Adherens junction_Homo sapiens_hsa04520 | -0.0334434 |
| 98 | Platelet activation_Homo sapiens_hsa04611 | -0.0226110 |
| 99 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0201892 |
| 100 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0179181 |

